PACIRA BIOSCIENCES, INC. (PCRX) Net margin 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) net profit margin by fiscal year — reported net income divided by reported revenue.
1.0%FY2025 · since FY2016: -14.1% → 1.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 1.0% | +15.2 pp |
| FY2024 | -14.2% | -20.4 pp |
| FY2023 | 6.2% | +3.8 pp |
| FY2022 | 2.4% | -5.4 pp |
| FY2021 | 7.8% | -26.1 pp |
| FY2020 | 33.9% | +36.5 pp |
| FY2019 | -2.6% | -2.5 pp |
| FY2018 | -0.1% | +14.8 pp |
| FY2017 | -15.0% | -0.9 pp |
| FY2016 | -14.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice